# CX-5461-sensitivity-signature-in-ovarian-cancer

Scripts to reproduce results and figures in: 

"CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer" by

Elaine Sanij, Katherine M. Hannan,  Jiachen Xuan, Shunfei Yan,  Jessica E. Ahern, 
Anna S. Trigos, Natalie Brajanovski, Jinbae Son,  Keefe T. Chan,  Olga Kondrashova, 
Elizabeth Lieschke, Matthew J. Wakefield, Daniel Frank, Sarah Ellis, Carleen Cullinane, 
Jian Kang, Gretchen Poortinga, Purba Nag, Andrew J. Deans, Kum Kum Khanna, Linda Mileshkin, 
Grant A. McArthur, John Soong, Els M.J.J. Berns, Ross D Hannan, Clare L. Scott, 
Karen E Sheppard and Richard B Pearson

Published in Nature Communications:
https://www.nature.com/articles/s41467-020-16393-4
